| pubmed-article:2557550 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2557550 | lifeskim:mentions | umls-concept:C1458155 | lld:lifeskim |
| pubmed-article:2557550 | lifeskim:mentions | umls-concept:C0431085 | lld:lifeskim |
| pubmed-article:2557550 | lifeskim:mentions | umls-concept:C0205332 | lld:lifeskim |
| pubmed-article:2557550 | lifeskim:mentions | umls-concept:C1883709 | lld:lifeskim |
| pubmed-article:2557550 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
| pubmed-article:2557550 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:2557550 | pubmed:dateCreated | 1990-1-26 | lld:pubmed |
| pubmed-article:2557550 | pubmed:abstractText | We have shown, in a preliminary report, that macrophages can induce strand breaks in the DNA of co-cultured tumor cells (Chong et al., 1988). The present study is designed to determine if oxygen-centered species generated by the cell-free enzyme-substrate combination of hypoxanthine and xanthine oxidase can induce similar lesions and to identify the specific mediator(s). We report that co-incubation of murine mammary tumor cell lines with hypoxanthine and xanthine oxidase leads to the induction of DNA-strand breaks as determined by fluorescence analysis of DNA unwinding (FADU) assay or alkaline elution techniques. This damage is preventable by catalase which removes hydrogen peroxide but no protection is provided by agents to remove or prevent the formation of superoxide anion (superoxide dismutase), or hydroxyl radical (mannitol or the iron chelator o-phenanthroline). Likewise, cyclooxygenase or lipoxygenase inhibitors of arachidonate metabolism (indomethacin, nordihydroguaiaretic acid, caffeic acid) or bromophenacyl bromide do not alter the degree of DNA scission. Treatment with higher doses of oxygen species leads to significant toxicity as determined by evaluation of cell growth potential or colony-forming ability. Again, toxicity is prevented only by the presence of catalase. Tumor cells are able to rejoin strand breaks at lower, less toxic doses. When comparing different tumor cell subpopulations at various stages of progression, i.e., metastatic vs. nonmetastatic, for sensitivity to hydrogen peroxide-induced strand breakage, we found that at lower concentrations (less than 5 microM) metastatic populations are sensitive whereas nonmetastatic populations exhibit no significant breakage. At higher concentrations of hydrogen peroxide, all lines were sensitive, suggesting that a lower threshold of sensitivity may exist for more progressed tumor cell lines. | lld:pubmed |
| pubmed-article:2557550 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557550 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2557550 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557550 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2557550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2557550 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2557550 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:2557550 | pubmed:issn | 0027-5107 | lld:pubmed |
| pubmed-article:2557550 | pubmed:author | pubmed-author:HeppnerG HGH | lld:pubmed |
| pubmed-article:2557550 | pubmed:author | pubmed-author:PaulL ALA | lld:pubmed |
| pubmed-article:2557550 | pubmed:author | pubmed-author:FultonA MAM | lld:pubmed |
| pubmed-article:2557550 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2557550 | pubmed:volume | 215 | lld:pubmed |
| pubmed-article:2557550 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2557550 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2557550 | pubmed:pagination | 223-34 | lld:pubmed |
| pubmed-article:2557550 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:meshHeading | pubmed-meshheading:2557550-... | lld:pubmed |
| pubmed-article:2557550 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2557550 | pubmed:articleTitle | Reactive oxygen-mediated damage to murine mammary tumor cells. | lld:pubmed |
| pubmed-article:2557550 | pubmed:affiliation | Department of Immunology, Michigan Cancer Foundation, Detroit. | lld:pubmed |
| pubmed-article:2557550 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2557550 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:2557550 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2557550 | lld:pubmed |
